Research has found that standard care drugs do not affect the activity of senescent primary human lung fibroblasts. It is unclear if alternative treatments are being explored for this specific issue, as other studies are investigating various modulation techniques for different conditions. The focus of these other studies includes neuroimmune modulation, autonomic modulation, and positive allosteric modulation for a range of diseases, but their connection to senescent lung fibroblasts is not specified.